No. 7: Any reason to take issue with 3D-printed human tissue?
May 08, 2018•29 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
On BIV Today…
Hosts Kirk LaPointe and Tyler Orton ask the question: can we soon expect transplants from 3D-printed organs made using B.C. technology? The BIV tech panel (1:14) talks about Aspect Biosystems’ efforts to commercialize its human tissue innovations. The panel then delves into the economic uncertainty surrounding Tesla and how it bled into a testy earnings call with Elon Musk.
Later, BIV reporter Patrick Blennerhassett (14:58) joins the show to discuss commentary from the World Economic Forum that examines how China intends to follow through with plans to reduce pollution.
Check out the Business in Vancouver team’s stories at https://biv.com.
Hosts Kirk LaPointe and Tyler Orton ask the question: can we soon expect transplants from 3D-printed organs made using B.C. technology? The BIV tech panel (1:14) talks about Aspect Biosystems’ efforts to commercialize its human tissue innovations. The panel then delves into the economic uncertainty surrounding Tesla and how it bled into a testy earnings call with Elon Musk.
Later, BIV reporter Patrick Blennerhassett (14:58) joins the show to discuss commentary from the World Economic Forum that examines how China intends to follow through with plans to reduce pollution.
Check out the Business in Vancouver team’s stories at https://biv.com.
See omnystudio.com/listener for privacy information.
For the best experience, listen in Metacast app for iOS or Android